M. Grogan et al., Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement, AM J CARD, 85(5), 2000, pp. 664
Citations number
4
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Survival of greater than or equal to 5 years was seen in 8 of 153 patients
(5%) with primary systemic amyloidosis and cardiac involvement. All patient
s with survival of >5 years received chemotherapy and all but 1 had an obje
ctive chemotherapeutic response.